Hospitalized Patients With COVID-19 May Experience Long-term Physical and Psychological Symptoms

March 17th 2021, 3:07pm


Patients discharged from hospitals after recovering from severe COVID-19 were found to have lasting functional impairment and post-traumatic stress symptoms months after, according to a study.

What We’re Reading: COVID-19 Screening Guidance; Eli Lilly Verzenio Results; Long-Haul Symptom Improvement

March 17th 2021, 2:24pm


The FDA issues updated guidance on the emergency use authorization (EUA) process for COVID-19 screening tools; Eli Lilly releases patient-reported outcome results for Verzenio (abemaciclib) in breast cancer; COVID-19 vaccines possibly improve long-haul symptoms among patients.

Study Highlights Impact of Sex, Age With More Severe Asthma

March 9th 2021, 1:00pm


Female patients and those under age 50 have a greater risk of severe asthma exacerbations and a lower health-related quality of life, despite having better lung function compared with male and older patients.

Encouraging Patients With Asthma to Exercise Easier Said Than Done, Survey Finds

March 6th 2021, 3:30pm


Asthma and immunology specialists responding to a survey about physical activity for patients with asthma were mostly unaware of any guidelines but seemed willing to learn more about how to incorporate them into practice.

Nearly 40% of Chronic Cough Cases Remain Unexplained After Extensive Testing, Therapy

March 5th 2021, 10:30pm


Despite receiving specialty referrals and multiple prescriptions medications, nearly 40% of patients with an unexplained chronic cough are not given a proper diagnosis.

FDA Grants EUA for J&J's 1-Dose COVID-19 Vaccine

February 27th 2021, 11:20pm


The FDA granted emergency use authorization (EUA) for the distribution of the nation's third COVID-19 vaccine, and on Sunday, a CDC panel will meet to decide on recommendations to put it into practice.

J&J’s COVID-19 Vaccine Moves Forward After FDA Panel Vote

February 26th 2021, 10:07pm


An FDA advisory panel Friday unanimously endorsed the third US COVID-19 vaccine, a 1-shot vaccine produced by Janssen, a subsidiary of Johnson & Johnson (J&J), and an emergency use authorization by the FDA is expected to follow shortly.

Flu Vaccine May Protect Against COVID-19 Infection

February 24th 2021, 8:13pm


A recent study found that patients immunized against influenza were less likely to test positive for or have serious complication related to coronavirus disease 2019 (COVID-19).

What We’re Reading: J&J Vaccine Will Go Before FDA; Cancer Survivor Concerns; Wasted COVID-19 Vaccine Doses

February 24th 2021, 3:26pm


An FDA committee will discuss emergency use authorization of the coronavirus disease 2019 (COVID-19) vaccine from Johnson & Johnson (J&J); American Cancer Society issues a report on cancer survivor concerns; Tennessee is found to have wasted thousands of vaccine doses.

Further Research Needed to Optimize Benefit of Gabapentin, Baclofen in Chronic Cough

February 19th 2021, 5:30pm


Gabapentin and baclofen can improve chronic refractory cough caused by gastroesophageal reflux disease, but efficacy is limited and further study needed.